Protective mechanisms of resveratrol against methotrexate‐induced renal damage may involve BCRP/ABCG2

Publisher： John Wiley & Sons Inc

E-ISSN： 1472-8206|30|5|406-418

ISSN： 0767-3981

Source： Fundamental & Clinical Pharmacology, Vol.30, Iss.5, 2016-10, pp. : 406-418

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Acyclovir is a substrate for the human breast cancer resistance protein (BCRP/ABCG2): implications for renal tubular transport and acyclovir-induced nephrotoxicity

By Gunness Patrina   Aleksa Katarina   Koren Gideon  

Canadian Journal of Physiology and Pharmacology, Vol. 89, Iss. 9, 2011-07 ,pp. : 675-680

NRC Research Press

Access to resources Recommend Favorite

Functional Analysis of SNPs Variants of BCRP/ABCG2

By Kondo Chihiro   Suzuki Hiroshi   Itoda Masaya   Ozawa Shogo   Sawada Jun-ichi   Kobayashi Daisuke   Ieiri Ichiro   Mine Kazunori   Ohtsubo Kenji   Sugiyama Yuichi  

Pharmaceutical Research, Vol. 21, Iss. 10, 2004-10 ,pp. : 1895-1903

Springer Publishing Company

Access to resources Recommend Favorite

Interaction of Isoflavones with the BCRP/ABCG2 Drug Transporter

By  

Current Drug Metabolism, Vol. 16, Iss. 2, 2015-01 ,pp. : 124-140

Bentham Science Publishers

Access to resources Recommend Favorite

Interaction of Probenecid with the Breast Cancer Resistance Protein Transporter (BCRP/ABCG2)

By  

Letters in Drug Design & Discovery, Vol. 3, Iss. 4, 2006-05 ,pp. : 236-241

Bentham Science Publishers

Access to resources Recommend Favorite

Structure and Function of the Human Breast Cancer Resistance Protein (BCRP/ABCG2)

By  

Current Drug Metabolism, Vol. 11, Iss. 7, 2010-09 ,pp. : 603-617

Bentham Science Publishers

Access to resources Recommend Favorite